Register information Patent

DE file number : 60 2014 080 066.1 (Status: pending/in force, Query started: May 22, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2014 080 066.1
96EP file numberEAKZ18 15 8586.0
97EP publication numberEPN3381917
54Designation/titleTIIMIDAZOPYRIDINVERBINDUNGEN UND VERWENDUNGEN DAVON
51IPC main classICM
(ICMV)		 C07D 471/04 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 31/437 (2006.01), A61K 31/4545 (2006.01), A61K 31/5377 (2006.01), A61K 31/4025 (2006.01), A61P 29/00 (2006.01), A61B 5/11 (2006.01)
22DE application dateDATJan 31, 2014
96EP application dateEATJan 31, 2014
43Date of first publicationOTOct 3, 2018
Date of publication of grantPETSep 8, 2021
71/73Applicant/ownerINHGlaxoSmithKline Intellectual Property (No. 3) Limited, Stevenage, GB
72InventorINBUON, Christophe, Montréal, Québec H4S 1Z9, CA; CANTIN, Louis-David, Montréal, Québec H4S 1Z9, CA; HU, Yun-Jin, Montréal, Québec H4S 1Z9, CA; LUO, Xuehong, Montréal, Québec H4S 1Z9, CA; TOMASZEWSKI, Miroslaw Jerzy, Montréal, Québec H4S 1Z9, CA
74RepresentativeVTRHoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE
Address for service HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201361759123 P
Jan 31, 2013
Due dateFT
FG		Jan 31, 2026
Annual fee for the 13th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003381917A1
Searchable text: EP000003381917A1
Original document: EP000003381917B1
Searchable text: EP000003381917B1
43Date of first publicationEVTOct 3, 2018
Date of the first transfer into DPMAregisterEREGTOct 3, 2018
Date of the (most recent) update in DPMAregisterREGTJan 11, 2025
(Show all update days)(Hide all update days)
  • Jan 11, 2025
    • Due date: changed
  • Nov 12, 2024
    • Representative: changed
  • Sep 26, 2024
    • St.36: changed (technical change)
  • May 16, 2024; Mar 21, 2024; Feb 13, 2024; Jan 6, 2024; Feb 2, 2023; Aug 18, 2022; Jul 28, 2022; Feb 3, 2022; Sep 7, 2021; Aug 19, 2021; Aug 22, 2019; Apr 18, 2019
    • Historical data not available for this/these date(s)
  • Oct 3, 2018
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Oct 3, 2018  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Nov 15, 2018 Nov 15, 2018 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Sep 8, 2021  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Sep 23, 2021 Sep 23, 2021 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jun 9, 2022 Sep 1, 2022 Details anzeigen
6 New applicant/owner details New applicant/owner details Feb 12, 2024 Mar 21, 2024 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTOct 3, 2018
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTNov 15, 2018
Issue numberHN46
YearPJ2018
Publication dateVTNov 15, 2018
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTSep 8, 2021
Date of update of the procedureREGTAug 19, 2021
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTSep 23, 2021
Issue numberHN38
YearPJ2021
Publication dateVTSep 23, 2021
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTSep 7, 2021
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJun 9, 2022
Issue numberHN35
YearPJ2022
Publication dateVTSep 1, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTAug 18, 2022
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTFeb 12, 2024
Issue numberHN12
YearPJ2024
Publication dateVTMar 21, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHGlaxoSmithKline Intellectual Property (No. 3) Limited, Stevenage, GB
71/73Previous applicant/ownerINHFBellus Health Cough Inc., Laval, Québec, CA
Date of update of the procedureREGTMar 21, 2024